Mechanisms of type III interferon expression.

Type III interferons (IFNs; IFN-lambda) are antiviral cytokines with type I IFN-like biological functions, including antiviral activity. In this article we review the literature on IFN-lambda expression and propose that important differences exist between the mechanisms governing expression of the different classes of IFNs. Importantly, while IFN-beta is induced by coordinated action of a multifactor enhanceosome, and IFN-alpha expression is activated by multiple IFN regulatory factor (IRF)-binding cis-promoter elements, the type III IFNs are induced through independent actions of IRFs and nuclear factor-kappaB. Although these differences may appear minor at first glance, we propose that IFN-lambda expression is more flexible than IFN-alpha/beta expression, which could allow expression of type III IFNs in response to a wider range of stimuli compared with type I IFNs. Moreover, such a mechanism of induction will potentially render expression of type III IFNs less sensitive to microbial evasion strategies targeting the IRF pathway. Thus, the mechanisms governing type III IFN expression play an important part in dictating the biology of this antiviral cytokine.

[1]  S. Paludan,et al.  Expression of Type III Interferon (IFN) in the Vaginal Mucosa Is Mediated Primarily by Dendritic Cells and Displays Stronger Dependence on NF-κB than Type I IFNs , 2010, Journal of Virology.

[2]  K. Früh,et al.  Human Cytomegalovirus Induces the Interferon Response via the DNA Sensor ZBP1 , 2009, Journal of Virology.

[3]  David B. Goldstein,et al.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.

[4]  R. Locksley,et al.  Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands , 2009, Nature Immunology.

[5]  K. Ishii,et al.  A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP , 2009, The Journal of experimental medicine.

[6]  Zhijian J. Chen,et al.  RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway , 2009, Cell.

[7]  M. Reed,et al.  Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide , 2009, The Journal of experimental medicine.

[8]  P. Génin,et al.  The role of differential expression of human interferon--a genes in antiviral immunity. , 2009, Cytokine & growth factor reviews.

[9]  V. Hornung,et al.  RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediate , 2009, Nature Immunology.

[10]  S. Kotenko,et al.  The role of transposable elements in the regulation of IFN-λ1 gene expression , 2009, Proceedings of the National Academy of Sciences.

[11]  G. Gallagher,et al.  IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells. , 2009, Blood.

[12]  D. Weiner,et al.  Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. , 2009, Blood.

[13]  T. Mogensen Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses , 2009, Clinical Microbiology Reviews.

[14]  K. Hartshorn,et al.  Differentiated Human Alveolar Type II Cells Secrete Antiviral IL-29 (IFN-λ1) in Response to Influenza A Infection1 , 2009, The Journal of Immunology.

[15]  D. Golenbock,et al.  TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. , 2008, Cell host & microbe.

[16]  D. Thanos,et al.  Virus Infection Induces NF-κB-Dependent Interchromosomal Associations Mediating Monoallelic IFN-β Gene Expression , 2008, Cell.

[17]  S. Akira,et al.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β , 2008, Nature Immunology.

[18]  U. Jensen,et al.  An Important Role for Type III Interferon (IFN-λ/IL-28) in TLR-Induced Antiviral Activity1 , 2008, The Journal of Immunology.

[19]  C. Coban,et al.  TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines , 2008, Nature.

[20]  S. Kotenko,et al.  IFN Regulatory Factor Family Members Differentially Regulate the Expression of Type III IFN (IFN-λ) Genes1 , 2007, The Journal of Immunology.

[21]  A. Smahi,et al.  TLR3 Deficiency in Patients with Herpes Simplex Encephalitis , 2007, Science.

[22]  S. Akira,et al.  Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. , 2007, Immunity.

[23]  K. Honda,et al.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.

[24]  S. Akira,et al.  Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism* , 2007, Journal of Biological Chemistry.

[25]  K. Honda,et al.  Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors , 2006 .

[26]  Stephen T Holgate,et al.  Role of deficient type III interferon-λ production in asthma exacerbations , 2006, Nature Medicine.

[27]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[28]  S. Paludan,et al.  Lambda Interferon (IFN-λ), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo , 2006, Journal of Virology.

[29]  A. Shahangian,et al.  Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response , 2006, Nature.

[30]  M. Mann,et al.  Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 , 2006, Nature.

[31]  K. Honda,et al.  Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction , 2005, Nature.

[32]  Hideo Negishi,et al.  IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.

[33]  R. Bartenschlager,et al.  Interferon type I gene expression in chronic hepatitis C , 2004, Laboratory Investigation.

[34]  Shizuo Akira,et al.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.

[35]  V. A. Stewart,et al.  Malaria Blood Stage Parasites Activate Human Plasmacytoid Dendritic Cells and Murine Dendritic Cells through a Toll-Like Receptor 9-Dependent Pathway1 , 2004, The Journal of Immunology.

[36]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[37]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[38]  E. Coccia,et al.  Viral infection and Toll‐like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte‐derived dendritic cells , 2004, European journal of immunology.

[39]  J. Dai,et al.  Comparative analysis of IRF and IFN‐alpha expression in human plasmacytoid and monocyte‐derived dendritic cells , 2003, Journal of leukocyte biology.

[40]  T. Giese,et al.  Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.

[41]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[42]  D. Levy,et al.  Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7 , 1998, The EMBO journal.

[43]  S. Kotenko,et al.  IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. , 2007, Journal of immunology.

[44]  R. Medzhitov,et al.  Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. , 2006, Immunity.

[45]  S. Johnston,et al.  Role of deficient type III interferon-lambda production in asthma exacerbations. , 2006, Nature medicine.

[46]  A. Lewis-Antes,et al.  IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. , 2003, Nature immunology.

[47]  Scott R. Presnell,et al.  IL-28, IL-29 and their class II cytokine receptor IL-28R , 2002, Nature Immunology.

[48]  J. V. Falvo,et al.  Structure and Function of the Interferon-β Enhanceosome , 1998 .